Omixon is pleased to announce our Lunch Symposium at the 2017 EFI Meeting in Mannheim, which will focus on automation of Holotype HLA for routine HLA genotyping and the experiences of existing Holotype HLA users in Europe and the Middle East. Dr. Alexandre Walencik from the Etablissement Français du Sang (EFS), Nantes, Dr. Mette Christiansen from Aarhus University Hospital, and Dr. Reem Ameen from Kuwait University are going to share their experience with the audience. Omixon’s CEO, Tim Hague will announce major product innovations and new directions for the company.
Password: EFI2017
Event High-throughput Automation of Holotype HLA in Clinical Routine
Room Gustav Mahler III, Rosengarten Conference Center
Date Wednesday, 31 May, 2017
Time 1:30pm-2:30pm CEST
Room Gustav Mahler III, Rosengarten Conference Center
Date Wednesday, 31 May, 2017
Time 1:30pm-2:30pm CEST
Agenda
- Welcome and Introduction by Marcello Scala (Sales Director, EMEA, Omixon)
- Announcement of Major Product Enhancements by Tim Hague (CEO, Omixon)
- Presentations by Guest Speakers
